Johns Hopkins Medicine สาธารณะ
[search 0]
เพิ่มเติม

ดาวน์โหลดแอปเลย!

show episodes
 
The Center for Nursing Inquiry oversees the scholarly work of nurses in the Johns Hopkins Health System. Our goal is to build the capacity for nurses to participate in the three forms of inquiry: research, evidence-based practice (EBP), and quality improvement (QI). At the Center for Nursing Inquiry, we offer a variety of educational resources and expert guidance to help nurses engage in meaningful, high-quality scholarly work. We are dedicated to advancing the science of nursing. Stay conne ...
 
Loading …
show series
 
HPV causes cancer, and we have an effective vaccine against it. Now the World Health Organization is advocating for a single dose of the vaccine in places where completing the two dose regimen is challenging. Johns Hopkins Kimmel Cancer Center director William Nelson applauds the strategy. Nelson: A single HPV dose might be effective for […]…
 
Men who used the diabetes medicine metformin during the three months prior to conception of their son saw malformations of the genital and urinary tracts three and a half times more often in these children, a very large study from Denmark finds. Johns Hopkins diabetes expert Rita Kalyani explains. Kalyani: What they found was that […]…
 
HPV causes cancer, and we have an effective vaccine against it. Now the World Health Organization is advocating for a single dose of the vaccine in places where completing the two dose regimen is challenging. Johns Hopkins Kimmel Cancer Center director William Nelson applauds the strategy. Nelson: A single HPV dose might be effective for […]…
 
HPV causes cancer, and we have an effective vaccine against it. Now the World Health Organization is advocating for a single dose of the vaccine in places where completing the two dose regimen is challenging. Johns Hopkins Kimmel Cancer Center director William Nelson applauds the strategy. Nelson: A single HPV dose might be effective for […]…
 
HPV causes cancer, and we have an effective vaccine against it. Now the World Health Organization is advocating for a single dose of the vaccine in places where completing the two dose regimen is challenging. Johns Hopkins Kimmel Cancer Center director William Nelson applauds the strategy. Nelson: A single HPV dose might be effective for […]…
 
Breakthrough infections, which occur in those who have been vaccinated against Covid-19, are more troubling for people with cancer than those without, a new study confirms. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, reviews the data. Nelson: The severity was also concerning. If you looked among the people who got an […]…
 
Breakthrough infections, which occur in those who have been vaccinated against Covid-19, are more troubling for people with cancer than those without, a new study confirms. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, reviews the data. Nelson: The severity was also concerning. If you looked among the people who got an […]…
 
Breakthrough infections, which occur in those who have been vaccinated against Covid-19, are more troubling for people with cancer than those without, a new study confirms. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, reviews the data. Nelson: The severity was also concerning. If you looked among the people who got an […]…
 
Breakthrough infections, which occur in those who have been vaccinated against Covid-19, are more troubling for people with cancer than those without, a new study confirms. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, reviews the data. Nelson: The severity was also concerning. If you looked among the people who got an […]…
 
People with cancer who have been vaccinated against Covid-19 remain at increased risk for infection compared with people who don’t have cancer, a very large new study reveals. Johns Hopkins Kimmel Cancer Center director William Nelson describes the findings. Nelson: In the end they had 45,000 or more cancer patients who had been vaccinated. And […]…
 
People with cancer who have been vaccinated against Covid-19 remain at increased risk for infection compared with people who don’t have cancer, a very large new study reveals. Johns Hopkins Kimmel Cancer Center director William Nelson describes the findings. Nelson: In the end they had 45,000 or more cancer patients who had been vaccinated. And […]…
 
People with cancer who have been vaccinated against Covid-19 remain at increased risk for infection compared with people who don’t have cancer, a very large new study reveals. Johns Hopkins Kimmel Cancer Center director William Nelson describes the findings. Nelson: In the end they had 45,000 or more cancer patients who had been vaccinated. And […]…
 
People with cancer who have been vaccinated against Covid-19 remain at increased risk for infection compared with people who don’t have cancer, a very large new study reveals. Johns Hopkins Kimmel Cancer Center director William Nelson describes the findings. Nelson: In the end they had 45,000 or more cancer patients who had been vaccinated. And […]…
 
An immunotherapy agent called nivolumab given before surgery in people with lung cancer dramatically lengthened the interval before cancer returned, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, is thrilled. Nelson: Will we slowly but surely get to point where the treatments are good enough that maybe you…
 
An immunotherapy agent called nivolumab given before surgery in people with lung cancer dramatically lengthened the interval before cancer returned, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, is thrilled. Nelson: Will we slowly but surely get to point where the treatments are good enough that maybe you…
 
An immunotherapy agent called nivolumab given before surgery in people with lung cancer dramatically lengthened the interval before cancer returned, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, is thrilled. Nelson: Will we slowly but surely get to point where the treatments are good enough that maybe you…
 
An immunotherapy agent called nivolumab given before surgery in people with lung cancer dramatically lengthened the interval before cancer returned, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, is thrilled. Nelson: Will we slowly but surely get to point where the treatments are good enough that maybe you…
 
Nivolumab is the name of an immunotherapy used to treat cancer, and a recent study of people with lung cancer using it before surgery shows it really helps. Johns Hopkins Kimmel Cancer Center director William Nelson explains. Nelson: Three hundred fifty-eight people randomized to receive the immunotherapy or not, along with chemotherapy before surg…
 
Nivolumab is the name of an immunotherapy used to treat cancer, and a recent study of people with lung cancer using it before surgery shows it really helps. Johns Hopkins Kimmel Cancer Center director William Nelson explains. Nelson: Three hundred fifty-eight people randomized to receive the immunotherapy or not, along with chemotherapy before surg…
 
Nivolumab is the name of an immunotherapy used to treat cancer, and a recent study of people with lung cancer using it before surgery shows it really helps. Johns Hopkins Kimmel Cancer Center director William Nelson explains. Nelson: Three hundred fifty-eight people randomized to receive the immunotherapy or not, along with chemotherapy before surg…
 
Nivolumab is the name of an immunotherapy used to treat cancer, and a recent study of people with lung cancer using it before surgery shows it really helps. Johns Hopkins Kimmel Cancer Center director William Nelson explains. Nelson: Three hundred fifty-eight people randomized to receive the immunotherapy or not, along with chemotherapy before surg…
 
Do you use e-cigarettes? If you’re a younger person you may have started out using them occasionally but are now a more regular user, or you may have attempted to quit be haven’t been able to do so. That’s what’s been shown in recent studies, and Michael Blaha, an anti-smoking advocate and cardiologist at Johns […]…
 
Do you use e-cigarettes? If you’re a younger person you may have started out using them occasionally but are now a more regular user, or you may have attempted to quit be haven’t been able to do so. That’s what’s been shown in recent studies, and Michael Blaha, an anti-smoking advocate and cardiologist at Johns […]…
 
Do you use e-cigarettes? If you’re a younger person you may have started out using them occasionally but are now a more regular user, or you may have attempted to quit be haven’t been able to do so. That’s what’s been shown in recent studies, and Michael Blaha, an anti-smoking advocate and cardiologist at Johns […]…
 
Do you use e-cigarettes? If you’re a younger person you may have started out using them occasionally but are now a more regular user, or you may have attempted to quit be haven’t been able to do so. That’s what’s been shown in recent studies, and Michael Blaha, an anti-smoking advocate and cardiologist at Johns […]…
 
If you’ve been using electronic cigarettes and attempt to quit but can’t, are you addicted? That’s one interpretation of a recent study among US youth, showing that since the introduction of e-cigarettes more unsuccessful quit attempts have been seen. Michael Blaha, an anti-smoking advocate and cardiologist at Johns Hopkins, says he’s persuaded. Bl…
 
If you’ve been using electronic cigarettes and attempt to quit but can’t, are you addicted? That’s one interpretation of a recent study among US youth, showing that since the introduction of e-cigarettes more unsuccessful quit attempts have been seen. Michael Blaha, an anti-smoking advocate and cardiologist at Johns Hopkins, says he’s persuaded. Bl…
 
If you’ve been using electronic cigarettes and attempt to quit but can’t, are you addicted? That’s one interpretation of a recent study among US youth, showing that since the introduction of e-cigarettes more unsuccessful quit attempts have been seen. Michael Blaha, an anti-smoking advocate and cardiologist at Johns Hopkins, says he’s persuaded. Bl…
 
If you’ve been using electronic cigarettes and attempt to quit but can’t, are you addicted? That’s one interpretation of a recent study among US youth, showing that since the introduction of e-cigarettes more unsuccessful quit attempts have been seen. Michael Blaha, an anti-smoking advocate and cardiologist at Johns Hopkins, says he’s persuaded. Bl…
 
Youth who take up vaping may have difficulty quitting, a recent analysis from the Monitoring the Future study looking at nicotine use among US 8th, 10th and 12th graders finds. Michael Blaha, an anti-smoking advocate and cardiologist at Johns Hopkins, says he’s seen another disturbing trend. Blaha: During the pandemic we’re seeing a decrease in occ…
 
Youth who take up vaping may have difficulty quitting, a recent analysis from the Monitoring the Future study looking at nicotine use among US 8th, 10th and 12th graders finds. Michael Blaha, an anti-smoking advocate and cardiologist at Johns Hopkins, says he’s seen another disturbing trend. Blaha: During the pandemic we’re seeing a decrease in occ…
 
Youth who take up vaping may have difficulty quitting, a recent analysis from the Monitoring the Future study looking at nicotine use among US 8th, 10th and 12th graders finds. Michael Blaha, an anti-smoking advocate and cardiologist at Johns Hopkins, says he’s seen another disturbing trend. Blaha: During the pandemic we’re seeing a decrease in occ…
 
Youth who take up vaping may have difficulty quitting, a recent analysis from the Monitoring the Future study looking at nicotine use among US 8th, 10th and 12th graders finds. Michael Blaha, an anti-smoking advocate and cardiologist at Johns Hopkins, says he’s seen another disturbing trend. Blaha: During the pandemic we’re seeing a decrease in occ…
 
While fewer young people seem to be taking up vaping, those who have are having a hard time quitting, recent research shows. Michael Blaha, an anti-smoking advocate and cardiologist at Johns Hopkins, says the very nature of the devices lend themselves to nicotine addiction. Blaha: With the recent products on the market as far as […]…
 
Loading …

คู่มืออ้างอิงด่วน

Google login Twitter login Classic login